• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine

Drug Database Powered by:

  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Month: June 2021

Pharma & Human Health

MaaT Pharma Announces DSMB Approval to Proceed to Cohort 4 out of 5 in Phase 1b CIMON Trial Testing Capsule Formulation of Microbiome Ecosystem Therapy

June 28, 2021 Microbiome Times

MaaT Pharma, a clinical-stage biotechnology company focused on developing Microbiome Ecosystem Therapies in oncology, today announced that the Data Safety and Monitoring Board (DSMB) recommended to proceed to the fourth cohort of the dose-finding Phase […]

Pharma & Human Health

Dieting and its effect on the gut microbiome

June 23, 2021 Microbiome Times

Researchers from Charité – Universitätsmedizin Berlin and the University of California in San Francisco were able to show for the first time that a very low calorie diet significantly alters the composition of the microbiota […]

Finance

Microbiotica’s Live Bacterial Therapeutic, MB097, in development to begin clinical trials in 2022 in immuno-oncology

June 23, 2021 Microbiome Times

Microbiotica, a leading player in microbiome-based therapeutics and biomarkers, today announces that MB097 is now in pre-clinical development for treatment of patients not responding to anti-PD1 therapy. Clinical trials are due to begin in 2022. […]

Finance

Synlogic Enters Research Collaboration with Roche for Development of Novel Therapy to Treat Inflammatory Bowel Disease

June 22, 2021 Microbiome Times

Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, announced today that it has entered into a research collaboration agreement with Roche for the discovery of a […]

Pharma & Human Health

Beyond synthetic biology, synthetic ecology boosts health by engineering the environment

June 21, 2021 Microbiome Times

There’s a lot of interest right now in how different microbiomes–like the one made up of all the bacteria in our guts–could be harnessed to boost human health and cure disease. But Daniel Segrè has […]

Pharma & Human Health

Researchers explore microbial ecosystem in search of drugs to fight SARS-CoV-2

June 20, 2021 Microbiome Times

Researchers from Yonsei University in South Korea have found that certain commensal bacteria that reside in the human intestine produce compounds that inhibit SARS-CoV-2. Previous clinical findings have shown that some patients with moderate to […]

Pharma & Human Health

A new study by ImmunoBiome-POSTECH research team identifies new drug candidate targeting multiple sclerosis and inflammatory bowel disease

June 16, 2021 Microbiome Times

Encouraging results are obtained from research carried out to develop novel treatments for inflammatory bowel disease, an intractable hypersensitive immune disease of the intestine, and multiple sclerosis, an autoimmune disease of the brain and spinal […]

Pharma & Human Health

New research identifies link between gut microbes and stroke

June 16, 2021 Microbiome Times

New findings from Cleveland Clinic researchers show for the first time that the gut microbiome impacts stroke severity and functional impairment following stroke. The results, published in Cell Host & Microbe, lay the groundwork for […]

Pharma & Human Health

New Double-Blind Randomized Placebo-Controlled Trial Confirms Hafnia alvei HA4597® helps improve weight loss in overweight adults

June 15, 2021 Nina Vinot

A collaboration between TargEDys, the French Institute of Research Inserm, Rouen Normandy University and Hospital, and Analyze-Realize in Berlin led to the publication of the first ever human trial on the efficacy of the novel […]

Pharma & Human Health

Healthy Microbiome Designed by Gusto Global Shows Promise to Radically Change Treatment for Inflammatory Diseases

June 11, 2021 Microbiome Times

Gusto Global, a leading microbiome discovery platform company focused on restoring a healthy microbiome, has developed novel consortia of bacteria that shows promise as a “breakthrough” therapy for treating Crohn’s disease and ulcerative colitis in […]

Finance

Osel Announces Positive Results from Phase 1b Trial of Live Biotherapeutic Product CBM588 in Combination with CPI Therapy in Metastatic Renal Cell Carcinoma

June 9, 2021 Microbiome Times

Osel Inc., a company developing live biotherapeutic products (LBPs) for diseases linked to the disruption of the human microbiome, announced that City of Hope, a world-renowned independent cancer and diabetes research and treatment center, presented […]

Posts navigation

1 2 »

Sign Up to Free Newsletter

The Microbiome Drug Database

Editor’s Choice

  • EXPERT’Biome CDMO by Lallemand at Microbiome Times Forum
    June 23, 2025
  • DynaMAP – Precision Metagenomics beyond Sequencing
    May 27, 2025
  • The Selection of a Pre-Clinical Model is Driven by the Specific Research Question
    May 13, 2025
  • Mental Health and the Brain-Gut-Microbiota Axis: Fundamental Importance of Diet
    April 3, 2025
  • Novel In vitro Model Replicates Intestinal Microbiota Composition Without Requiring Anaerobic Incubation
    March 25, 2025
sign up

Sign up to the Microbiome Times newsletter